We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Individual Intervention for Men in Focused Deterrence Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03184116
Recruitment Status : Not yet recruiting
First Posted : June 12, 2017
Last Update Posted : December 13, 2017
Sponsor:
Information provided by (Responsible Party):
Sylvie Mrug, University of Alabama at Birmingham

Brief Summary:
This project will implement and evaluate a community-based intervention to improve individual outcomes in violence-related injuries and homicide. Young African American men participating in a focused deterrence program (the Birmingham Violence Reduction Initiative, BVRI) will be randomized to receive an additional individual intervention based on the cognitive-behavioral Reasoning and Rehabilitation program.

Condition or disease Intervention/treatment
Violence Behavioral: Individual intervention

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Reducing Violence Among High Risk African American Men in Focused Deterrence Program Through Individual Support
Anticipated Study Start Date : March 2018
Estimated Primary Completion Date : October 2018
Estimated Study Completion Date : June 2019

Arm Intervention/treatment
Experimental: Individual intervention
Individual intervention using cognitive-behavioral principles
Behavioral: Individual intervention
Individual intervention based on a cognitive-behavioral program Reasoning & Rehabilitation
No Intervention: Control
No additional intervention



Primary Outcome Measures :
  1. Violence [ Time Frame: 6 months ]
    involvement in violent incidents based on police records and self-report



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 30 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • African American male identified as at high risk for violence by the Birmingham Violence Reduction Initiative

Exclusion Criteria:

  • Mental retardation, serious mental illness (eg, psychosis)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03184116


Contacts
Contact: Sylvie Mrug, PhD 2059759462 smrug@uab.edu

Sponsors and Collaborators
University of Alabama at Birmingham

Responsible Party: Sylvie Mrug, Professor, University of Alabama at Birmingham
ClinicalTrials.gov Identifier: NCT03184116     History of Changes
Other Study ID Numbers: 1
First Posted: June 12, 2017    Key Record Dates
Last Update Posted: December 13, 2017
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No